We are live on ! Find out more
CNST

Constellation Pharmaceuticals, Inc.
CNST

Delisted

CNST was delisted on the 14th of July, 2021.

0 hedge funds and large institutions have $0 invested in Constellation Pharmaceuticals, Inc. in 2021 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 153 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 1530 (-153)

100% less funds holding in top 10

Funds holding in top 10: 90 (-9)

100% less capital invested

Capital invested by funds: $1.42B → $0 (-$1.42B)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 153

Holders
Holders Change
-153
Holders Change %
-100%
% of All Funds
Holding in Top 10
Holding in Top 10 Change
-9
Holding in Top 10 Change %
-100%
% of All Funds
New
Increased
Reduced
Closed
153
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
Citigroup
26
Citigroup
New York
-$16.8M -496,548 Closed
PHS
27
PFM Health Sciences
California
-$15.9M -469,664 Closed
Morgan Stanley
28
Morgan Stanley
New York
-$15.8M -467,442 Closed
SRC
29
Samson Rock Capital
United Kingdom
-$15.8M -467,072 Closed
Goldman Sachs
30
Goldman Sachs
New York
-$15.5M -458,096 Closed
CC
31
Commodore Capital
New York
-$14.9M -440,869 Closed
GF
32
Gabelli Funds
New York
-$12.9M -380,583 Closed
Allianz Asset Management
33
Allianz Asset Management
Germany
-$12.1M -358,697 Closed
Northern Trust
34
Northern Trust
Illinois
-$12M -356,234 Closed
CCM
35
Chicago Capital Management
Illinois
-$10M -295,878 Closed
TAL
36
TIG Advisors LLC
New York
-$9.72M -287,643 Closed
E
37
Ergoteles
New York
-$9.49M -280,900 Closed
CS
38
Candriam SCA
Luxembourg
-$9.46M -280,008 Closed
NAM
39
Nexpoint Asset Management
Texas
-$8.98M -265,794 Closed
PAMP
40
Polar Asset Management Partners
Ontario, Canada
-$8.64M -255,665 Closed
RSCM
41
Rock Springs Capital Management
Maryland
-$8.36M -247,200 Closed
Charles Schwab
42
Charles Schwab
California
-$7.62M -225,435 Closed
BHMP
43
Bardin Hill Management Partners
New York
-$7.44M -219,997 Closed
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
44
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Ontario, Canada
-$6.98M -206,400 Closed
GCIA
45
Gabelli & Co Investment Advisers
New York
-$6.17M -182,618 Closed
BL
46
Bleichroeder LP
New York
-$6.17M -182,500 Closed
FTCM
47
First Trust Capital Management
Illinois
-$5.92M -175,036 Closed
LP
48
LMR Partners
United Kingdom
-$5.6M -165,643 Closed
Norges Bank
49
Norges Bank
Norway
-$5.37M -158,900 Closed
DAM
50
DLD Asset Management
New York
-$5.07M -150,000 Closed

CNST Hedge Fund Activity: Q3 2021 in Review

0 of the 5,713 institutional investors tracked by Wall St. Rank reported a position in Constellation Pharmaceuticals, Inc. (CNST) for Q3 2021, worth a combined $0 — down 100% from $1.42B a quarter earlier.

Sellers outnumbered buyers: 153 funds closed out of CNST and 0 opened new positions — a net loss of 153 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Avoro Capital Advisors, exiting entirely with an estimated $108M sold.

  • 0 institutional investors held Constellation Pharmaceuticals, Inc. (CNST) as of Q3 2021, down from 153 in Q2 2021.
  • Funds reported $0 of Constellation Pharmaceuticals, Inc. stock for Q3 2021, down 100% quarter-over-quarter.
  • 0 funds opened new Constellation Pharmaceuticals, Inc. positions in Q3 2021 and 153 closed out, a net change of -153 holders.
  • The largest Constellation Pharmaceuticals, Inc. seller in Q3 2021 was Avoro Capital Advisors, an estimated $108M sold.

Based on aggregated 13F filings for Q3 2021.